Morphic Holding, Inc. Common Stock (MORF)

MORF was delisted on the 15th of August, 2024.

• Market cap: $2.86B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.

Employees: 128